Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial.

Bilezikian, John P; Hattersley, Gary; Mitlak, Bruce H; Hu, Ming-Yi; Fitzpatrick, Lorraine A; Dabrowski, Christine; Miller, Paul D; Papapoulos, Socrates E.
Curr Med Res Opin; : 1-6, 2019 Sep 11.
Artigo em Inglês | MEDLINE | ID: mdl-31418585